Brentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies

By Gualberto Antonio  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 205-216

Informa Healthcare

Access to resources Recommend Favorite

Interferon (IFN)- plus bexarotene were effective in the treatment of multi focal, cutaneous, CD30+, large T cell lymphoma

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1201-1210

Bentham Science Publishers

Access to resources Recommend Favorite

Autologous Peripheral Stem-cell Transplantation after Intensive Chemotherapy in a Case of CD30 (Ki-1)-Positive Anaplastic Large-cell Lymphoma

By Tsuda T   Matsunami M   Nakayama K   Hara J   Sakaguchi R   Katayama N   Okamoto Y   Ota K  

The Journal of International Medical Research, Vol. 29, Iss. 5, 2001-09 ,pp. : 425-431

Field House Publishing

Access to resources Recommend Favorite

Targeting the Epigenome in Hematopoietic Malignancies

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 242-252

Bentham Science Publishers

Access to resources Recommend Favorite